Fundraising FoxFlying L Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Aurion Biotechaurionbiotech.cominApr 2022 · $120M
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsVisionary VenturesDeerfield Management Company
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.